SITC Archive Library

Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products 

01-05-2022 16:42

The Society for Immunotherapy of Cancer (SITC) hosted "Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products" during the 36th Annual Meeting & Pre-Conference Programs on November 13, 2021. Available here are the presentation slides and video from the session, as permitted by presenters.

 

36th Annual Meeting Organizers

  • Niroshana Anandasabapathy, MD, PhD – Weill Cornell Medicine
  • Paolo A. Ascierto, MD – Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
  • Margaret K. Callahan, MD, PhD – Memorial Sloan Kettering Cancer Center
  • Michelle Rohlfs, APRN, FNP-BC, AOCNP – The University of Texas MD Anderson Cancer Center

Annual Program Committee

  • Chair: Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center
  • Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center
  • Lorenzo Falchi, MD – Memorial Sloan Kettering Cancer Center
  • Brianna Hoffner, MSN, ANP-BC, AOCNP – Harborside
  • Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai

Session Co-Chairs:

  • Emily Hopewell, PhD – Indiana University
  • Alessandra Cesano, MD, PhD – ESSA Pharma, Inc.
  • Cecila Yeung, MD – Fred Hutchinson Cancer Research Center
  • Raj K. Puri, MD, PhD – Food and Drug Administration

 

To view the entire program schedule (including presenter permission to post) please click here

Statistics
0 Favorited
51 Views
3 Files
0 Shares
41 Downloads
Attachment(s)
pdf file
manufacturing throughout development – Unmodified agents"...   1.17 MB   1 version
Uploaded - 01-05-2022
Program: SITC 36th Annual Meeting: Sunday Sessions; Session 304: Phase-Dependent Regulatory Considerations in Manufacturing of Cellular Therapy Products; Presenter: Robert Pierce, MD – Sensei Therapeutics; Date: November 14, 2021

Related Entries and Links

No Related Resource entered.